Search Results

There are 119678 results for: content related to: Multiple squamous cell carcinomas following treatment with sorafenib for renal cell carcinoma

  1. You have free access to this content
    A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

    BJU International

    Volume 107, Issue 8, April 2011, Pages: 1190–1199, Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders and Camillo Porta

    Version of Record online : 15 NOV 2010, DOI: 10.1111/j.1464-410X.2010.09829.x

  2. You have free access to this content
    Incidence and Risk of Sorafenib-Induced Hypertension: A Systematic Review and Meta-Analysis

    The Journal of Clinical Hypertension

    Volume 16, Issue 3, March 2014, Pages: 177–185, Yan Li, Shun Li, Yaofeng Zhu, Xinyue Liang, Hui Meng, Jun Chen, Dongqing Zhang, Hu Guo and Benkang Shi

    Version of Record online : 12 MAR 2014, DOI: 10.1111/jch.12273

  3. Meta-analysis of dermatological toxicities associated with sorafenib

    Clinical and Experimental Dermatology

    Volume 36, Issue 4, June 2011, Pages: 344–350, L. Zhang, Q. Zhou, L. Ma, Z. Wu and Y. Wang

    Version of Record online : 20 APR 2011, DOI: 10.1111/j.1365-2230.2011.04060.x

  4. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

    British Journal of Dermatology

    Volume 161, Issue 5, November 2009, Pages: 1045–1051, W.J. Lee, J.L. Lee, S.E. Chang, M.W. Lee, Y.K. Kang, J.H. Choi, K.C. Moon and J.K. Koh

    Version of Record online : 5 MAY 2009, DOI: 10.1111/j.1365-2133.2009.09290.x

  5. You have free access to this content
    Interim analysis of START: Study in asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trial

    International Journal of Cancer

    Volume 132, Issue 10, 15 May 2013, Pages: 2448–2458, Young-Hwa Chung, Guohong Han, Jung-Hwan Yoon, Jijin Yang, Jianhua Wang, Guo-Liang Shao, Byung Ik Kim, Teng-Yu Lee and Yee Chao

    Version of Record online : 28 NOV 2012, DOI: 10.1002/ijc.27925

  6. Sorafenib-induced premalignant and malignant skin lesions

    International Journal of Dermatology

    Volume 50, Issue 4, April 2011, Pages: 396–402, Victoria L. Williams, Philip R. Cohen and David J. Stewart

    Version of Record online : 18 MAR 2011, DOI: 10.1111/j.1365-4632.2010.04822.x

  7. You have free access to this content
    ABT-263 enhances sorafenib-induced apoptosis associated with Akt activity and the expression of Bax and p21(CIP1/WAF1) in human cancer cells

    British Journal of Pharmacology

    Volume 171, Issue 13, July 2014, Pages: 3182–3195, Jingru Li, Yicheng Chen, Jiali Wan, Xin Liu, Chunrong Yu and Wenhua Li

    Version of Record online : 10 JUN 2014, DOI: 10.1111/bph.12659

  8. Characteristics of 18 patients with hepatocellular carcinoma who obtained a complete response after treatment with sorafenib

    Hepatology Research

    Volume 44, Issue 13, December 2014, Pages: 1268–1276, Satoshi Shiba, Takuji Okusaka, Masafumi Ikeda, Hidetsugu Saito and Takafumi Ichida

    Version of Record online : 18 FEB 2014, DOI: 10.1111/hepr.12297

  9. You have free access to this content
    Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib – the role of extracellular signal-regulated kinase counteraction

    The FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3494–3507, Irena Manov, Yulia Pollak, Rinata Broneshter and Theodore C. Iancu

    Version of Record online : 5 SEP 2011, DOI: 10.1111/j.1742-4658.2011.08271.x

  10. You have full text access to this Open Access content
    Low-dose taxotere enhances the ability of sorafenib to induce apoptosis in gastric cancer models

    Journal of Cellular and Molecular Medicine

    Volume 15, Issue 2, February 2011, Pages: 316–326, Anna Tesei, Carlo Leonetti, Gabriella Zupi, Marco Scarsella, Giovanni Brigliadori, Paola Ulivi, Francesco Fabbri, Chiara Arienti, Dino Amadori, Alessandro Passardi, Rosella Silvestrini and Wainer Zoli

    Version of Record online : 8 DEC 2009, DOI: 10.1111/j.1582-4934.2009.00993.x

  11. You have free access to this content
    The Adverse Effects of Sorafenib in Patients with Advanced Cancers

    Basic & Clinical Pharmacology & Toxicology

    Volume 116, Issue 3, March 2015, Pages: 216–221, Ye Li, Zu-Hua Gao and Xian-Jun Qu

    Version of Record online : 14 JAN 2015, DOI: 10.1111/bcpt.12365

  12. You have free access to this content
    Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update

    Hepatology Research

    Volume 43, Issue 2, February 2013, Pages: 147–154, Angela Gauthier and Mitchell Ho

    Version of Record online : 12 NOV 2012, DOI: 10.1111/j.1872-034X.2012.01113.x

  13. You have full text access to this OnlineOpen article
    FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity

    Pharmacology Research & Perspectives

    Volume 3, Issue 5, October 2015, Dilruba Ahmed, Petra J. de Verdier, Charlotta Ryk, Oscar Lunqe, Per Stål and Jenny Flygare

    Version of Record online : 19 AUG 2015, DOI: 10.1002/prp2.171

  14. Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography

    Hepatology Research

    Volume 45, Issue 9, September 2015, Pages: 976–985, Hisashi Hidaka, Takahide Nakazawa, Shigeru Fujii, Michiko Yanagihara, Tsutomu Minamino, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Akitaka Shibuya and Wasaburo Koizumi

    Version of Record online : 11 DEC 2014, DOI: 10.1111/hepr.12440

  15. You have free access to this content
    The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis

    Cancer

    Volume 118, Issue 21, 1 November 2012, Pages: 5293–5301, Joanne Chiu, Yuen Fong Tang, Tzy-Jyun Yao, Ashley Wong, Hilda Wong, Roland Leung, Pierre Chan, Tan To Cheung, Albert C. Chan, Roberta Pang, Sheung-Tat Fan, Ronnie Poon and Thomas Yau

    Version of Record online : 19 APR 2012, DOI: 10.1002/cncr.27543

  16. Angiokinase Inhibitors

    Targeting Protein Kinases for Cancer Therapy

    David J. Matthews, Mary E. Gerritsen, Pages: 527–565, 2010

    Published Online : 11 MAR 2010, DOI: 10.1002/9780470555293.ch9

  17. You have free access to this content
    Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 692–698, Cristina Masini, Roberto Sabbatini, Camillo Porta, Giuseppe Procopio, Giuseppe Di Lorenzo, Azzurra Onofri, Sebastiano Buti, Roberto Iacovelli, Roberta Invernizzi, Luca Moscetti, Maria Giuseppina Aste, Maria Pagano, Federica Grosso, Anna Lucia Manenti, Cinzia Ortega, Laura Cosmai, Cinzia Del Giovane and Pier Franco Conte

    Version of Record online : 24 FEB 2012, DOI: 10.1111/j.1464-410X.2012.10946.x

  18. Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line

    Diseases of the Esophagus

    Volume 21, Issue 6, September 2008, Pages: 514–521, R. N. Keswani, A. Chumsangsri, R. Mustafi, J. Delgado, E. E. W. Cohen and M. Bissonnette

    Version of Record online : 19 OCT 2007, DOI: 10.1111/j.1442-2050.2007.00799.x

  19. Phase I Trial of Sorafenib in Combination With 5-Fluorouracil/Leucovorin in Advanced Solid Tumors

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 656–669, Dr Einat Shacham-Shmueli, Dr Ravit Geva, Dr Arie Figer, Dr Sarah Bulocinic, Dr Karen Nalbandyan, Dr Shulim Shpigel, Dr Jacob Atsmon and Dr Erich Brendel

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011404027

  20. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways

    Journal of Cellular Physiology

    Volume 224, Issue 1, July 2010, Pages: 112–119, Gang Wei, Meifang Wang and Brian I. Carr

    Version of Record online : 18 MAR 2010, DOI: 10.1002/jcp.22099